Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

NCT05160532 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05160532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2022
Completion date
May 31, 2025
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis